MedDataX Logo

Development of MRI Protocols and Associated Explorations (EEG, NIRS) in Voluntary Patients

NCT ID: NCT03160235

Last Updated: 2021-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-02-01

Study Completion Date

2021-07-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies that will be carried out on healthy volunteers will have as main objective the development and optimization of the parameters of sequences or the design of the paradigms of stimulation in order to optimize the quality and the relevance of the images realized taking in Taking account of anatomical, functional or metabolic parameters, or integrating new approaches resulting from technical evolutions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The pathologies that interest us in these refinements concern mainly the chronic (or sequellar) brain disorders which can be degenerative, developmental or vascular. The patients who will be recruited will be known patients of our Service (University Clinic of Neuroradiology and MRI) that we follow during checks. The type of examination that will be applied to them, between MRI, EEG and NIRS, will be specified in the consent form. These examinations will not be invoiced either to the patient or to the social security, and the related costs will be borne by our Federative Research Structure or sometimes, when these explorations are upstream of a defined research protocol and funded, They will be financed under this protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Magnetic Resonance Imaging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Methodological development of new MRI approaches
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Magnetic resonance imaging

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Development of MRI protocols

MRI exam to grade differents interventions for future research

Group Type EXPERIMENTAL

Magnetic resonance imaging

Intervention Type RADIATION

Development of EEG protocols

EEF exam to grade differents interventions for future research

Group Type EXPERIMENTAL

EEG

Intervention Type DEVICE

Development of NIRS protocols

NIRS exam to grade differents interventions for future research

Group Type EXPERIMENTAL

NIRS

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic resonance imaging

Intervention Type RADIATION

EEG

Intervention Type DEVICE

NIRS

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* major voluntary patients
* socially insured.
* Karnofsky score above 60%.
* given their consent.
* absence of contraindication to the MRI examination

Exclusion Criteria

* Subjects under the age of 18
* pregnant women
* persons referred to in articles L1121-5 to L1121-8 of the CSP.
* Patients with acute illness
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Grenoble-Alpes

Grenoble, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

38RC12.239

Identifier Type: -

Identifier Source: org_study_id